Premium
Portage Biotech Inc (PRTG)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets ... Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.22 | -4.51745379877 | 4.87 | 5 | 4.39 | 21187 | 4.69723883 | CS |
| 4 | 0.65 | 16.25 | 4 | 5.5 | 3.8 | 135928 | 4.50736628 | CS |
| 12 | 0.43 | 10.1895734597 | 4.22 | 12.89 | 2.95 | 790774 | 8.5703844 | CS |
| 26 | 2.24 | 92.9460580913 | 2.41 | 23.01 | 2.3 | 1230053 | 8.06072287 | CS |
| 52 | -6.55 | -58.4821428571 | 11.2 | 23.01 | 2.098 | 866929 | 7.1087623 | CS |
| 156 | -158.15 | -97.1437346437 | 162.8 | 239.8 | 2.098 | 306820 | 12.44003991 | CS |
| 260 | -745.35 | -99.38 | 750 | 899.526 | 2.098 | 238404 | 27.19453647 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
